InterVenn Biosciences Announces Clinical Validation of World’s First Glycoproteomic Diagnostic Test

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- #AI--InterVenn Biosciences announces it has completed clinical and analytical validation of GLORI, a liquid-biopsy diagnostic test for female pelvic tumors

Click to view original post